XOMA Xoma Corp

XOMA Corp is a biotechnology company. It discovers and develops human and humanized monoclonal antibody-based therapeutics.

$20.84
As of 07/01/2022     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/19/2012
Outstanding shares:  11,420,935
Average volume:  85,526
Market cap:   $254,458,432
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYP7GF0

---

Valuation   (See tab for details)

---

PE ratio:   19.77
PB ratio:   1.70
PS ratio:   6.22
Return on equity:   14.93%
Net income %:   51.09%